tiprankstipranks
TipRanksTop Financial ExpertsInsidersKUSH PARMAR

KUSH PARMAR Insider Profile

11 Followers
KUSH PARMAR, Director at Entrada Therapeutics Inc, holds 3.78M shares in Entrada Therapeutics Inc (Ticker: TRDA), holds 181.44K shares in Q32 Bio (Ticker: QTTB), holds ― shares in Audentes Therapeutics (Ticker: ~BOLD). Most recently, KUSH PARMAR Sold ― shares of Entrada Therapeutics Inc on Aug 10, 2026 for an estimated value of $1.08M.
See the Hottest Stocks Based on Insider Trading >
tipranks
KUSH PARMAR

KUSH PARMAR
Entrada Therapeutics Inc (TRDA)
Director

Ranked #6,219 out of 108,699 Corporate Insiders

Profitable Transactions

57%
12 out of 21 Profitable Transactions

Average Return

+18.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$136M
45.23%
31.30%
21.28%
2.18%
0.01% Others
A breakdown of KUSH PARMAR's holdings
See the Top Stocks by Insiders

Insider Roles

Rallybio
(RLYB)
Director
Vor Biopharma
(VOR)
Director, Ten Percent Owner
Entrada Therapeutics Inc
(TRDA)
Director
Q32 Bio
(QTTB)
Director
+1 other positions
Roles that KUSH PARMAR holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Vor Biopharma
(VOR)
Rating:Informative Sell
Date:Nov 18, 2021 - Nov 18, 2022
Return:+69.50%
The most profitable trade made by KUSH PARMAR
See the Latest Stocks Traded by Insiders

KUSH PARMAR's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TRDA
Entrada Therapeutics Inc
Aug 10, 2026
Director
Informative Sell
1.08M
$28.84M
QTTB
Q32 Bio
Dec 28, 2020
Director
Informative Sell
6.41M
$2.96M
~BOLD
Audentes Therapeutics
―
―
―
―
SCPH
scPharmaceuticals
―
―
―
―
ARVN
Arvinas Holding Company
Sep 26, 2019
Director
Uninformative Sell
―
$17.04K
AKUS
AKOUOS
Dec 02, 2022
―
Uninformative Sell
―
$0.00
FVAM
5:01 Acquisition Corp Class A
Nov 12, 2020
―
Uninformative Buy
51.26K
$3.65M
VOR
Vor Biopharma
Nov 18, 2021
Director, Ten Percent Owner
Informative Sell
5.06M
$42.42M
RLYB
Rallybio
Mar 09, 2023
Director
Informative Sell
820.00K
$61.30M
List of latest transactions for each holding click on a transaction to see KUSH PARMAR's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

KUSH PARMAR insider profile FAQ

What is the percentage of profitable transactions made by KUSH PARMAR?
The percentage of profitable transactions made by KUSH PARMAR is 57%.
    What is the average return per transaction made by KUSH PARMAR?
    The average return per transaction made by KUSH PARMAR is 18.40%.
      What stocks does KUSH PARMAR hold?
      KUSH PARMAR holds: TRDA, QTTB, ~BOLD, SCPH, ARVN, AKUS, FVAM, VOR, RLYB stocks.
        What was KUSH PARMAR’s latest transaction?
        KUSH PARMAR latest transaction was an Informative Sell of $1.08M.
          What was KUSH PARMAR's most profitable transaction?
          KUSH PARMAR’s most profitable transaction was an Informative Sell of VOR stock on November 18, 2021. The return on the trade was 69.50%.
            What is KUSH PARMAR's role in Entrada Therapeutics Inc?
            KUSH PARMAR's role in Entrada Therapeutics Inc is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.